Antibody-enhanced hepatitis E virus nanofiltration in the course of the manufacture

      No Comments on Antibody-enhanced hepatitis E virus nanofiltration in the course of the manufacture
controlpeptidecomprimary-antibodies

Antibody-enhanced hepatitis E virus nanofiltration in the course of the manufacture of human immunoglobulin

Background: Circulation of hepatitis E virus (HEV) in areas the place plasma is sourced for the manufacture of plasma-derived medicinal merchandise (PDMPs) has prompted verification of HEV clearance. HEV exists as quasi lipid-enveloped (LE) and non-lipid-enveloped (NLE) types, which is perhaps of relevance for HEV clearance from manufacturing processes of antibody-containing PDMPs with solvent/detergent (S/D) therapy upstream of additional clearance steps.
Research design and strategies: Presence of various HEV particles in shares utilized in clearance research was investigated, with nanofilters graded across the assumed HEV particle sizes and by gradient centrifugation. HEV elimination by 35-nm nanofiltration was investigated within the presence or absence of HEV antibodies, in buffer in addition to in immunoglobulin (IG) manufacturing course of intermediates.
Outcomes: HEV particles in step with LE, NLE, and an “intermediate” (IM) phenotype, obtained after S/D therapy, have been seen in several HEV shares. Within the absence of HEV antibodies, log discount components (LRFs) of 4.Zero and a couple of.5 have been obtained by 35-nm nanofiltration of LE and IM HEV, in step with the bigger and smaller sizes of those phenotypes. Addition of HEV antibodies enhanced IM HEV elimination round 1000-fold (LRF, 5.6). Efficient (LRF, >4.eight and >4.0) HEV elimination was obtained for the nanofiltration processing step for IG intermediates with various HEV antibody content material.
Conclusion: HEV spikes utilized in clearance research ought to be fastidiously chosen, as variations in physicochemical properties would possibly have an effect on HEV clearance. Antibody-mediated enhancement of HEV nanofiltration was demonstrated in IG course of intermediates even at low HEV antibody focus, illustrating the robustness of this manufacturing step.

Antibody-protein binding and conformational modifications: figuring out allosteric signalling pathways to engineer a greater effector response

 

Quite a few monoclonal antibodies have been developed efficiently for the therapy of varied ailments. However, the event of biotherapeutic antibodies is advanced, costly, and time-consuming, and to facilitate this course of, cautious structural evaluation past the antibody binding website is required to develop a extra efficacious antibody.
  • On this work, we targeted on protein antigens, since they induce the most important antibody modifications, and supply fascinating instances to check and distinction. The buildings of 15 anti-protein antibodies have been analysed to check the antigen-bound/unbound types.
  • Surprisingly, three different courses of binding-induced modificationshave beenrecognized. In school (B1), the antigen binding fragment distorted considerably, and we discovered modifications within the loop area of the heavy chain’s fixed area; this corresponds nicely with anticipated allosteric actions. In school (B2), we discovered modifications in the identical loop area with out the general distortion.
  • In school (B3), these modifications didn’t current, and solely local modificationson the complementarity figuring outareashave beendiscovered. Consequently, structural evaluation of antibodies is essential for therapeutic growth.
  • Cautious analysis of allosteric actionshave to be undertaken to develop higher effector responses, particularly in the course of the transformation of those antibodies from small fragments on the discovery stage to full antibodies on the subsequent growth levels.
controlpeptidecomprimary-antibodies

controlpeptidecomprimary-antibodies

PSMB8 Antibody
1-CSB-PA775839
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

PSMB8 Antibody
E043134 100μg/100μl
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody
1-CSB-PA018886GA01HU
  • Ask for price
  • Ask for price
  • 150ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF

PSMB8 Antibody
1-CSB-PA018886LA01HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

PSMB8 Antibody
E94054 100μg
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody
E97340 100ul
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody
E314816 100ug/200ul
EUR 295
Description: Available in various conjugation types.

PSMB8 antibody
70R-13550 100 ul
EUR 550
Description: Affinity purified Rabbit polyclonal PSMB8 antibody

PSMB8 antibody
70R-19589 50 ul
EUR 289
Description: Rabbit polyclonal PSMB8 antibody

PSMB8 Antibody
1-CSB-PA116429
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100

PSMB8 antibody
BF0434 100ug
EUR 355

PSMB8 Antibody
MBS7113266-005mL 0.05mL
EUR 190

PSMB8 Antibody
MBS7113266-01mL 0.1mL
EUR 270

PSMB8 Antibody
MBS7113266-5x01mL 5x0.1mL
EUR 1205

PSMB8 Antibody
MBS7129229-005mL 0.05mL
EUR 190

PSMB8 Antibody
MBS7129229-01mL 0.1mL
EUR 270

PSMB8 Antibody
MBS7129229-5x01mL 5x0.1mL
EUR 1205

PSMB8 Antibody
MBS7129230-005mL 0.05mL
EUR 190

PSMB8 Antibody
MBS7129230-01mL 0.1mL
EUR 270

PSMB8 Antibody
MBS7129230-5x01mL 5x0.1mL
EUR 1205

PSMB8 antibody
MBS9405580-01mL 0.1mL
EUR 420

PSMB8 antibody
MBS9405580-5x01mL 5x0.1mL
EUR 1740

PSMB8 Antibody
MBS8500013-01mg 0.1mg
EUR 325

PSMB8 Antibody
MBS8500013-01mLAF405L 0.1mL(AF405L)
EUR 565

PSMB8 Antibody
MBS8500013-01mLAF405S 0.1mL(AF405S)
EUR 565

PSMB8 Antibody
MBS8500013-01mLAF610 0.1mL(AF610)
EUR 565

PSMB8 Antibody
MBS8500013-01mLAF635 0.1mL(AF635)
EUR 565

PSMB8 Antibody
MBS5312424-01mL 0.1mL
EUR 1070

PSMB8 Antibody
MBS5312424-5x01mL 5x0.1mL
EUR 4655

PSMB8 Antibody
MBS9416351-01mL 0.1mL
EUR 305

PSMB8 Antibody
MBS9416351-5x01mL 5x0.1mL
EUR 1230

PSMB8 Antibody
BF0434-100ul 100ul
EUR 210
Description: WB,IHC,IF/ICC,ELISA

PSMB8 Antibody
BF0434-200ul 200ul Ask for price
Description: WB,IHC,IF/ICC,ELISA

PSMB8 Antibody
BF0434-50ul 50ul
EUR 150
Description: WB,IHC,IF/ICC,ELISA

PSMB8 Conjugated Antibody
C43134 100ul
EUR 476.4

PSMB8 Polyclonal Antibody
E-AB-92394-120uL 120uL
EUR 320
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-92394-200uL 200uL
EUR 530
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-92394-60uL 60uL
EUR 200
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-92394-each each Ask for price
Description: Unconjugated

PSMB8 Polyclonal Antibody
A73468 50 μl
EUR 557

PSMB8 Polyclonal Antibody
E-AB-61655-120uL 120uL
EUR 320
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-61655-200uL 200uL
EUR 530
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-61655-60uL 60uL
EUR 200
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-61655-each each Ask for price
Description: Unconjugated

PSMB8 Polyclonal Antibody
MBS2538339-006mL 0.06mL
EUR 190

PSMB8 Polyclonal Antibody
MBS2538339-012mL 0.12mL
EUR 265

PSMB8 Polyclonal Antibody
MBS2538339-02mL 0.2mL
EUR 415

PSMB8 Polyclonal Antibody
MBS2538339-5x02mL 5x0.2mL
EUR 1835

PSMB8 Polyclonal Antibody
MBS2527805-002mL 0.02mL
EUR 140

PSMB8 Polyclonal Antibody
MBS2527805-006mL 0.06mL
EUR 180

PSMB8 Polyclonal Antibody
MBS2527805-012mL 0.12mL
EUR 260

PSMB8 Polyclonal Antibody
MBS2527805-02mL 0.2mL
EUR 405

PSMB8 Polyclonal Antibody
MBS2527805-5x02mL 5x0.2mL
EUR 1725

PSMB8 Polyclonal Antibody
MBS2528965-002mL 0.02mL
EUR 140

PSMB8 Polyclonal Antibody
MBS2528965-006mL 0.06mL
EUR 180

PSMB8 Polyclonal Antibody
MBS2528965-012mL 0.12mL
EUR 260

PSMB8 Polyclonal Antibody
MBS2528965-02mL 0.2mL
EUR 405

PSMB8 Polyclonal Antibody
MBS2528965-5x02mL 5x0.2mL
EUR 1725

PSMB8 Conjugated Antibody
MBS9451453-01mLAF350 0.1mL(AF350)
EUR 480

PSMB8 Conjugated Antibody
MBS9451453-01mLAF405 0.1mL(AF405)
EUR 480

PSMB8 Conjugated Antibody
MBS9451453-01mLAF488 0.1mL(AF488)
EUR 480

PSMB8 Conjugated Antibody
MBS9451453-01mLAF555 0.1mL(AF555)
EUR 480

PSMB8 Conjugated Antibody
MBS9451453-01mLBiotin 0.1mL(Biotin)
EUR 480

PSMB8 Polyclonal Antibody
RD84433A-120uL 120μL
EUR 360
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.

PSMB8 Polyclonal Antibody
RD84433A-200uL 200μL
EUR 630
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.

PSMB8 Polyclonal Antibody
RD84433A-60uL 60μL
EUR 204
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.

PSMB8 Antibody (N-term)
MBS9213569-008mL 0.08mL
EUR 210

PSMB8 Antibody (N-term)
MBS9213569-04mL 0.4mL
EUR 430

PSMB8 Antibody (N-term)
MBS9213569-5x04mL 5x0.4mL
EUR 1910

PSMB8 Antibody, HRP conjugated
1-CSB-PA018886LB01HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

PSMB8 Antibody, HRP Conjugated
MBS7113267-005mL 0.05mL
EUR 190

PSMB8 Antibody, HRP Conjugated
MBS7113267-01mL 0.1mL
EUR 270

PSMB8 Antibody, HRP Conjugated
MBS7113267-5x01mL 5x0.1mL
EUR 1205

PSMB8 Antibody, FITC conjugated
1-CSB-PA018886LC01HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

OACD05288-1ML - PSMB8 Antibody
OACD05288-1ML 1ml
EUR 649

OACD05289-1ML - PSMB8 Antibody
OACD05289-1ML 1ml
EUR 659

OACD05290-1ML - PSMB8 Antibody
OACD05290-1ML 1ml
EUR 639

PSMB8 Antibody, FITC Conjugated
MBS7113268-005mL 0.05mL
EUR 190

PSMB8 Antibody, FITC Conjugated
MBS7113268-01mL 0.1mL
EUR 270

PSMB8 Antibody, FITC Conjugated
MBS7113268-5x01mL 5x0.1mL
EUR 1205

OAAN02231-50UL - PSMB8 Antibody
OAAN02231-50UL 50ul
EUR 149

PSMB8 Antibody, Biotin conjugated
1-CSB-PA018886LD01HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

OACD05288-100UL - PSMB8 Antibody
OACD05288-100UL 100ul
EUR 199

OACD05289-100UL - PSMB8 Antibody
OACD05289-100UL 100ul
EUR 189

OACD05290-100UL - PSMB8 Antibody
OACD05290-100UL 100ul
EUR 189

OAAN02231-100UL - PSMB8 Antibody
OAAN02231-100UL 100ul
EUR 249

OAAN02231-200UL - PSMB8 Antibody
OAAN02231-200UL 200ul
EUR 389

OAEB02189-100UG - PSMB8 Antibody
OAEB02189-100UG 100ug
EUR 349

OAGA01026-100UL - PSMB8 antibody
OAGA01026-100UL 100ul
EUR 369

PSMB8 Antibody, Biotin Conjugated
MBS7113269-005mL 0.05mL
EUR 190

PSMB8 Antibody, Biotin Conjugated
MBS7113269-01mL 0.1mL
EUR 270

PSMB8 Antibody, Biotin Conjugated
MBS7113269-5x01mL 5x0.1mL
EUR 1205

Human, Rat, Mouse PSMB8 antibody
P0987 100ul
EUR 150

PSMB8 Rabbit Polyclonal Antibody
55187 100ul
EUR 439

PSMB8 Rabbit Polyclonal Antibody
E10G05021 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

PSMB8 Rabbit Polyclonal Antibody
E10G11908 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

PSMB8 Rabbit Polyclonal Antibody
MBS9466218-005mL 0.05mL
EUR 300

 

Antibody profiling of a Borreliella burgdorferi (Lyme illness) C6 antibody optimistic, symptomatic Rottweiler and her pups

Lyme illness (LD) is a tick-transmitted illness attributable to Borreliella burgdorferi (Bb). Temporal research of maternal antibody (Ab) profiles in Bb contaminated pregnant canine and their pups haven’t been performed. On this research, Ab profiles of a client-owned Bb C6 Ab optimistic Rottweiler and her 9 pups have been assessed.
The dam introduced with lameness 12 days previous to parturition and was C6 Ab optimistic with a Quant C6 Ab focus of 237U/mL. Therapy with amoxicillin was initiated and 11 days later 9 pups have been delivered. Screening of the sera from the dam and pups towards Bb cell lysates and a panel of antigens revealed related immunoreactivity profiles.
Whereas antigen-specific IgG and IgM reactivity continued within the dam for at the least 7 months, a fast decline in IgG particular for BBA36, BBK53, BB0238, BBA73 and outer floor protein (Osp) E within the pups occurred between days 29 and 52 post-parturition. In distinction, Ab particular for DbpA and the diagnostic antigens VlsE (C6) and OspF, remained elevated within the pups.
Sera from the dam displayed potent complement-dependent bactericidal exercise towards Bb. Sera from the pups was additionally bactericidal however primarily by means of a complement-independent mechanism. Lastly, single dose vaccination of the dam at day 51 post-parturition with a LD subunit vaccine consisting of OspA and an OspC chimeritope triggered a broad anti-OspC Ab response indicative of an anamnestic response. Though this research targeted on a single case, these findings add to our data of maternal Ab profiles and can help the interpretation of serological assays in pups delivered by a Bb C6 Ab optimistic canine.

Human Resistin
90233-A 5 µg
EUR 130
Description: Recombinant Resistin is a disulfide-linked homodimeric protein consisting of two 93 amino acid residues, and migrates as an approximately 20 kDa protein under non-reducing conditions and as a 10 kDa protein under reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Resistin mature chain was expressed in E. coli.

Human Resistin
90233-B 25 µg
EUR 205
Description: Recombinant Resistin is a disulfide-linked homodimeric protein consisting of two 93 amino acid residues, and migrates as an approximately 20 kDa protein under non-reducing conditions and as a 10 kDa protein under reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Resistin mature chain was expressed in E. coli.

Human Resistin
MBS692069-0005mg 0.005mg
EUR 300

Human Resistin
MBS692069-0025mg 0.025mg
EUR 450

Human Resistin
MBS692069-5x0025mg 5x0.025mg
EUR 1725

Human resistin
MBS400069-001mg 0.01mg
EUR 220

Human resistin
MBS400069-005mg 0.05mg
EUR 545

Human resistin
MBS400069-01mg 0.1mg
EUR 770

Human resistin
MBS400069-1mg 1mg
EUR 3830

Human Resistin Antibody
32138-05111 150 ug
EUR 215

Human Resistin Antibody
GWB-F7AAE4 0.1 mg Ask for price

Resistin (43-65) (Human) - Antibody
H-028-39 50 μl
EUR 604.8

Resistin (51-108) (Human) - Antibody
H-028-40 50 μl
EUR 604.8

Resistin (43-65) (Human)
028-39 100 μg
EUR 255.96

Resistin (51-108) (Human)
028-40 20 μg
EUR 282.96

Resistin (23-42) (Human)
028-41 100 μg
EUR 214.92

Resistin (25-42) (Human)
028-42 100 μg
EUR 214.92

Mouse Anti-Human Resistin
MBS690775-05mg 0.5mg
EUR 525

Mouse Anti-Human Resistin
MBS690775-5x05mg 5x0.5mg
EUR 2080

Anti-Human Resistin Antibody
101-M170 500 µg
EUR 246.75
Description: Resistin belongs to a family of tissue-specific cytokines termed FIZZ (found in inflammatory zones) and RELM. The three known members of this family; Resistin, RELM-α and RELM-β share a highly conserved C-terminal domain, characterized by 10 cysteine residues with a unique spacing motif of C-X11-C-X8-C-X-C-X3-C-X10-C-X-C-X-C-X9-C-C. Resistin is an adipose-derived cytokine (adipokine) whose physiological function and molecular targets are largely unknown. Studies have shown that Resistin suppresses insulin's ability to stimulate glucose uptake, and postulated that Resistin might be an important link between obesity and Type 2 diabetes. Other studies have indicated that Resistin expression is severely suppressed in obesity and that it may act as a feedback regulator of Adipogenesis. Recombinant human Resistin is a 19.5 kDa disulfide-linked homodimeric protein composed of two identical 92 amino acid chains linked by a single disulfide bond.

Anti-Human Resistin Antibody
101-M618 100 µg
EUR 399
Description: Resistin belongs to a family of tissue-specific cytokines termed FIZZ (found in inflammatory zones) and RELM. The three known members of this family; Resistin, RELM-α and RELM-β share a highly conserved C-terminal domain, characterized by 10 cysteine residues with a unique spacing motif of C-X11-C-X8-C-X-C-X3-C-X10-C-X-C-X-C-X9-C-C. Resistin is an adipose-derived cytokine (adipokine) whose physiological function and molecular targets are largely unknown. Studies have shown that Resistin suppresses insulin's ability to stimulate glucose uptake, and postulated that Resistin might be an important link between obesity and Type 2 diabetes. Other studies have indicated that Resistin expression is severely suppressed in obesity and that it may act as a feedback regulator of Adipogenesis.

Anti-Human Resistin Antibody
102-P92G 100 µg
EUR 245.7
Description: Resistin belongs to a family of tissue-specific cytokines termed FIZZ (found in inflammatory zones) and RELM. The three known members of this family; Resistin, RELM-α and RELM-β share a highly conserved C-terminal domain, characterized by 10 cysteine residues with a unique spacing motif of C-X11-C-X8-C-X-C-X3-C-X10-C-X-C-X-C-X9-C-C. Resistin is an adipose-derived cytokine (adipokine) whose physiological function and molecular targets are largely unknown. Studies have shown that Resistin suppresses insulin's ability to stimulate glucose uptake, and postulated that Resistin might be an important link between obesity and Type 2 diabetes. Other studies have indicated that Resistin expression is severely suppressed in obesity and that it may act as a feedback regulator of Adipogenesis.

Human Resistin (RETN)
1-CSB-EP019573HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Resistin(RETN) expressed in E.coli

Human resistin antagonist
MBS400115-001mg 0.01mg
EUR 220

Human resistin antagonist
MBS400115-005mg 0.05mg
EUR 545

Human resistin antagonist
MBS400115-01mg 0.1mg
EUR 770

Human resistin antagonist
MBS400115-1mg 1mg
EUR 3830

Biotinylated Anti-Human Resistin
GWB-BIG87D 1 kit Ask for price

Recombinant Human Resistin
7-01519 5µg Ask for price

Recombinant Human Resistin
7-01520 25µg Ask for price

Recombinant Human Resistin
7-01521 1mg Ask for price

RECOMBINANT HUMAN RESISTIN
GWB-F4A137 0.02 mg Ask for price

Recombinant Human Resistin
cyt-456-1mg 1mg
EUR 4680

Recombinant Human Resistin
cyt-456-25g 25µg
EUR 145

Recombinant Human Resistin
cyt-456-5g 5µg
EUR 60

Recombinant Human Resistin
MBS7611410-005mg 0.05mg
EUR 345

Recombinant Human Resistin
MBS7611410-02mg 0.2mg
EUR 635

Recombinant Human Resistin
MBS7611410-1mg 1mg
EUR 1800

Recombinant Human Resistin
MBS7611410-5x1mg 5x1mg
EUR 6955

Recombinant Human Resistin
MBS142332-0005mg 0.005mg
EUR 240

Recombinant Human Resistin
MBS142332-0025mg 0.025mg
EUR 310

Recombinant Human Resistin
MBS142332-1mg 1mg
EUR 4895

Recombinant Human Resistin
MBS142332-5x1mg 5x1mg
EUR 21695

Recombinant Human Resistin
MBS1410331-002mgEColi 0.02mg(E-Coli)
EUR 255

Recombinant Human Resistin
MBS1410331-01mgEColi 0.1mg(E-Coli)
EUR 405

Recombinant Human Resistin
MBS1410331-1mgEColi 1mg(E-Coli)
EUR 1425

Recombinant Human Resistin
MBS1410331-5x1mgEColi 5x1mg(E-Coli)
EUR 6215

RECOMBINANT HUMAN RESISTIN
MBS232425-0025mg 0.025mg
EUR 510

RECOMBINANT HUMAN RESISTIN
MBS232425-5x0025mg 5x0.025mg
EUR 2130

Human Resistin Recombinant
MBS553192-0005mg 0.005mg
EUR 165

Human Resistin Recombinant
MBS553192-0025mg 0.025mg
EUR 245

Recombinant Human Resistin
MBS9420612-002mg 0.02mg
EUR 285

Recombinant Human Resistin
MBS9420612-01mg 0.1mg
EUR 470

Recombinant Human Resistin
MBS9420612-1mg 1mg
EUR 1785

Recombinant Human Resistin
MBS9420612-5x1mg 5x1mg
EUR 7885

Human Resistin CLIA Kit
MBS8425884-INQUIRE INQUIRE Ask for price

Resistin, human recombinant
4559-100 each
EUR 874.8

Resistin, human recombinant
4559-1000 each
EUR 6127.2

Resistin, human recombinant
4559-25 each
EUR 307.2

Resistin (Recombinant) Human
GWB-8EE40A 0.025 mg Ask for price

Resistin, recombinant (Human)
028-36 20 μg
EUR 423.36

Resistin Human Recombinant
rAP-0727 Inquiry Ask for price

Human Resistin ELISA kit
E01R0351-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Resistin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Resistin ELISA kit
E01R0351-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human Resistin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Resistin ELISA kit
E01R0351-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human Resistin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Resistin ELISA kit
E01A7519 96T
EUR 700
Description: ELISA

Human Resistin ELISA Kit
E16HE0035 96T
EUR 833.33

Human Resistin ELISA KIT
E16HE0035-048 48 wells
EUR 295

Human Resistin ELISA KIT
E16HE0035-096 96 wells
EUR 395

Human Resistin ELISA KIT
EKC40240-48T 48T
EUR 412.02

Human Resistin ELISA KIT
EKC40240-5x96T 5x96T
EUR 2795.85

Human Resistin ELISA KIT
EKC40240-96T 96T
EUR 588.6

Human Resistin ELISA KIT
E42EH-93 96T/48T Ask for price

Human Resistin ELISA kit
E22-HC136.48 48T
EUR 295

Human Resistin ELISA kit
E22-HC136.96 96T
EUR 395

Human Resistin ELISA Kit
E28L0045 96T
EUR 666.67

Human Resistin ELISA Kit
EK2351 96 tests
EUR 497

Human Resistin ELISA Kit
EHR0358 96Tests
EUR 625.2

Leave a Reply

Your email address will not be published. Required fields are marked *